Urologix, Inc. (ULGX) said Friday that it has priced its registered follow-on firm commitment underwritten public offering of 5.2 million shares of its common stock at a public offering price of $0.75 per share.
In addition, the company has granted the underwriter a 45-day option to purchase up to an additional 780,000 shares of its common stock to cover overallotments.
The public offering is expected to close on or about July 5.
The company plans to use the net proceeds from the offering to fund its sales and marketing initiatives, to make certain required payments related to its license of the Prostiva RF Therapy System technology, to support its research and development activities and for working capital and general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.